San Jose, CA, USA.
J Neurosci Res. 2021 Oct;99(10):2367-2376. doi: 10.1002/jnr.24917. Epub 2021 Jul 19.
Unusual mortality rate differences and symptoms have been experienced by COVID-19 patients, and the postinfection symptoms called Long COVID-19 have also been widely experienced. A substantial percentage of COVID-19-infected individuals in specific health categories have been virtually asymptomatic, several other individuals in the same health categories have exhibited several unusual symptoms, and yet other individuals in the same health categories have fatal outcomes. It is now hypothesized that these differences in mortality rates and symptoms could be caused by a SARS-CoV-2 virus infection acting together with one or more latent pathogen infections in certain patients, through mutually beneficial induced immune cell dysfunctions, including T-cell exhaustion. A latent pathogen infection likely to be involved is the protozoan parasite Toxoplasma gondii, which infects approximately one third of the global human population. Furthermore, certain infections and cancers that cause T-cell exhaustion can also explain the more severe outcomes of other COVID-19 patients having several disease and cancer comorbidities.
新冠病毒感染者出现了不同寻常的死亡率差异和症状,被称为“长新冠”的感染后症状也广泛存在。在特定健康类别中,相当一部分新冠病毒感染者实际上没有症状,同一健康类别中的其他一些人表现出了几种不寻常的症状,而同一健康类别中的其他一些人则出现了致命的后果。现在的假设是,这些死亡率和症状的差异可能是由 SARS-CoV-2 病毒感染与某些患者体内的一种或多种潜伏病原体感染共同作用引起的,通过相互有利的诱导免疫细胞功能障碍,包括 T 细胞耗竭。一种可能涉及的潜伏病原体感染是原虫寄生虫刚地弓形虫,它感染了大约全球三分之一的人口。此外,某些导致 T 细胞耗竭的感染和癌症也可以解释为什么其他新冠病毒感染者有几种疾病和癌症合并症,会出现更严重的后果。